Dow Down 0.22% Nasdaq Up 0.14%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
168.22 Up 1.75(1.05%) Aug 22, 4:00PM EDT
|After Hours : 168.22 0.00 (0.00%) Aug 22, 4:36PM EDT
Prev Close:166.47
Open:167.37
Bid:159.00 x 100
Ask:187.00 x 200
1y Target Est:197.05
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:164.62 - 168.98
52wk Range:100.89 - 185.43
Volume:734,288
Avg Vol (3m):1,174,950
Market Cap:33.28B
P/E (ttm):101.70
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 1.05%33.28B
AMGNUp 0.22%100.89B
BAXDown 1.00%40.65B

Key Statistics

Forward P/E (1 yr):29.10
P/S (ttm):17.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback